Shares in drug development company Actinogen Medical (ASX: ACW) have plummeted following the results release of their Phase 2a clinical…
With mixed quarter results for the June quarter, Holista Colltech (ASX: HCT) - a research-driven biotech company, is trying to…
A new drug seeking to treat irritability associated with Autism Spectrum Disorder (ASD) could soon be making its way to…
Biotechnology company Emyria (ASX: EMD), which develops treatments for mental health and neurological conditions, has newly inaugurated its treatment facility…
Biotech company Arovella Therapeutics (ASX: ALA), focused on developing its invariant Natural Killer T (iNKT) cell therapy platform for cancer…
Global molecular diagnostics company Genetic Signatures (ASX: GSS) has decided to halt the development of its EasyScreen Essentials Respiratory Detection…